[Renal effects of cyclopenthiazide in the newborn period].
D000284:Administration, Oral; D000367:Age Factors; D001581:Benzothiadiazines / Q000008:administration & dosage / Q000494:pharmacology*; D002118:Calcium / Q000652:urine; D002254:Carbonates / Q000652:urine; D002712:Chlorides / Q000652:urine; D003499:Cyclic S-Oxides / Q000008:administration & dosage / Q000494:pharmacology; D003517:Cyclopentanes / Q000008:administration & dosage / Q000494:pharmacology; D004232:Diuretics; D004573:Electrolytes / Q000008:administration & dosage; D006801:Humans; D006859:Hydrogen / Q000652:urine; D007231:Infant, Newborn; D007474:Ion Exchange; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D010710:Phosphates / Q000652:urine; D011188:Potassium / Q000652:urine; D000644:Quaternary Ammonium Compounds / Q000652:urine; D012636:Secretory Rate / Q000187:drug effects; D012964:Sodium / Q000652:urine; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*
D001581:Benzothiadiazines; D002254:Carbonates; D002712:Chlorides; D003499:Cyclic S-Oxides; D003517:Cyclopentanes; D004232:Diuretics; D004573:Electrolytes; D010710:Phosphates; D000644:Quaternary Ammonium Compounds; D049993:Sodium Chloride Symporter Inhibitors; D006859:Hydrogen; D012964:Sodium; D011188:Potassium; D002118:Calcium
Renale Wirkungen von Cyclopenthiazid in der Neugeborenenperiode